FDA NEWS

FDA Approves Entereg For Bowel Function Following Surgery - eMaxHealth.com
FDA approved Entereg (alvimopan) to accelerate the restoration of normal bowel function in patients 18 years and up who have undergone partial large or small bowel resection surgery. Entereg will be used in hospitalized patients who can receive no
Source: www.emaxhealth.com

Wyeth Receives Approvable Letter From FDA for Bazedoxifene for the - MSN MoneyCentral
COLLEGEVILLE, Pa., May 23 /PRNewswire/ -- Wyeth Pharmaceuticals, a division of Wyeth WYE , announced today that the U.S. Food and Drug Administration (FDA) issued an approvable letter on May 21 for bazedoxifene, a selective estrogen receptor
Source: news.moneycentral.msn.com

FDA-Medicare system aimed at drug safety - Herald Tribune
Published Friday, May 23, 2008 at 4:30 a.m. Last updated Friday, May 23, 2008 at 5:40 a.m. WASHINGTON — Two major government health agencies that have traditionally operated as self-contained bureaucratic fiefdoms Thursday announced a joint venture
Source: www.heraldtribune.com

Wyeth receives FDA approval letter for bazedoxifene - Forbes
BOSTON (Thomson Financial) - Wyeth Friday said it received an approval letter from the Food and Drug Administration for bazedoxifene, a selective estrogen receptor modulator, for the treatment of postmenopausal osteoporosis. In the letter, the FDA
Source: www.forbes.com

BIO Lauds Senate for FDA and NIH Funding Boosts - Forbes
The Food and Drug Administration and National Institutes of Health received much-needed funding increases in the FY 2008 Supplemental Appropriations bill the Senate passed today. In its $400 million appropriation to NIH, the Senate bill recognizes
Source: www.forbes.com

UPDATE 1-US delays approval of Wyeth osteoporosis medicine - Reuters
NEW YORK, May 23 (Reuters) - U.S. health regulators have delayed approval of Wyeth's (WYE.N: Quote , Profile , Research ) experimental medicine for treating osteoporosis, requesting information about blood clots and stroke, the drug maker said on
Source: www.reuters.com

FDA wants more data on Wyeth osteoporosis drug - Boston Globe
COLLEGEVILLE, Pa.— Wyeth said Friday that U.S. regulators have again denied approval of the drug maker's osteoporosis drug bazedoxifene requesting additional information on stroke and blood clot issues. The Food and Drug Administration issued Wyeth
Source: www.boston.com

Baxter weighs whether to sell heparin vials again in U.S. market - Chicago Tribune
Baxter International Inc. Chairman and Chief Executive Robert Parkinson is leaving open the possibility that the company may stay out of the business of selling vials of heparin in the U.S. market. The company recalled vials of the popular blood
Source: www.chicagotribune.com

FDA, Medicare to form early-warning drug network - Los Angeles Times
WASHINGTON -- Two major government health agencies that have traditionally operated as self-contained bureaucratic fiefdoms announced a joint venture Thursday that promises to improve prescription drug safety for all Americans, while potentially
Source: www.latimes.com

Labels: FDA